InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
6
T+90 hit rate
27%
T+90 mean return
-9.5%
Across 11 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Dahlquist Karl S., Directeur Juridique. Director active across 1 company, notably AtriCure, Inc.. Cumulatively, 18 filings have been logged. Split: 0 buy · 6 sells. Total volume traded: €799k. Activity tracked since 30 June 2021. The latest transaction was disclosed on 1 March 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations18 total
636 sharesCommon StockSEC:0001861996-26-000004:0
19,359 shares0Common StockSEC:0001323885-25-000019:0
707 shares@ US$19.351.5% of flowCommon StockSEC:0001323885-24-000100:0
1,885 shares@ US$32.166.3% of flowCommon StockSEC:0001323885-24-000046:0
8,231 shares@ US$37.3632.3% of flowCommon StockSEC:0001323885-24-000040:0
22,050 shares0Common StockSEC:0001323885-24-000035:0
1,248 shares@ US$34.434.6% of flowCommon StockSEC:0001323885-23-000112:0
3,417 shares@ US$57.0920.1% of flowCommon StockSEC:0001323885-23-000099:0
557 shares@ US$38.112.2% of flowCommon StockSEC:0001323885-23-000079:0
1,422 shares@ US$47.037.1% of flowCommon StockSEC:0001323885-23-000073:0
4,417 shares@ US$44.8320.6% of flowCommon StockSEC:0001323885-23-000049:0
8,036 shares0Common StockSEC:0001323885-23-000031:0
350 shares@ US$34.731.3% of flowCommon StockSEC:0001323885-22-000093:0
7,789 shares0Common StockSEC:0001323885-22-000023:0
24 shares@ US$59.100.0001% mcap3.5% of flowCommon StockSEC:0001209191-22-000384:0
24 shares@ US$59.100.1% of flowCommon StockSEC:0001209191-22-000384
428 shares@ US$45.721.9% of flowCommon StockSEC:0001209191-21-044872
428 shares@ US$45.720.0012% mcap46.5% of flowCommon StockSEC:0001209191-21-044872:0
18 of 18 declarations
About Dahlquist Karl S.
Karl S. Dahlquist is the Chief Legal Officer of AtriCure, Inc. In this role, he is responsible for overseeing the company's legal affairs, including regulatory compliance and risk management. Dahlquist plays a crucial role in protecting AtriCure's legal interests, ensuring that the company adheres to applicable laws and regulations. His expertise in business law is a valuable asset to the organization.
